As of June 21, 2025, American Medical Technologies Inc (ADLI) reports a Gross Margin of 53.24%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of American Medical Technologies Inc's Gross Margin
Over recent years, American Medical Technologies Inc's Gross Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2007-12-31 | 53.24% |
| 2006-12-31 | 49.22% |
| 2005-12-31 | 34.10% |
| 2004-12-31 | 46.92% |
| 2003-12-31 | 37.28% |
This slight downward trend highlights how American Medical Technologies Inc manages its operational efficiency and pricing power over time.
Comparing American Medical Technologies Inc's Gross Margin to Peers
To better understand American Medical Technologies Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| American Medical Technologies Inc (ADLI) | 53.24% |
| Bionoid Pharma Inc (BINP) | 7775.20% |
| Imagin Medical Inc (IME.CN) | 7775.20% |
| Quantrx Biomedical Corp (QTXB) | 100.00% |
| Echo Therapeutics Inc (ECTE) | 100.00% |
| Xcorporeal Inc (XCRP) | 97.83% |
Compared to its competitors, American Medical Technologies Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.